Ripa S, La Rosa F, Ghezzi A, Prenna M, Pfeffer M
Antimicrob Agents Chemother. 1982 Feb;21(2):323-6. doi: 10.1128/AAC.21.2.323.
The pharmacokinetic of ceforanide, a new parenteral cephalosporin antibiotic, were examined at intravenous and intramuscular doses of 250, 500, and 1,000 mg in healthy male volunteers. Over the above dosing range, ceforanide pharmacokinetics were essentially linear, with plasma clearances varying from 2.2 to 2.5 liters/h. The best present overall estimate of the drug's half-life was 2.9 h. Intramuscular ceforanide was 100% bioavailable, Peak intravenous serum levels were 39, 71, and 135 micrograms/ml at the end of 30-min infusions of 250, 500, and 1,000 mg; after intramuscular injections of 250, 500, and 1,000 mg, the respective peak serum levels were 21, 38, and 69 micrograms/ml. From 80 to 85% of the above doses were eliminated as unchanged.
在健康男性志愿者中,以250毫克、500毫克和1000毫克的静脉注射和肌肉注射剂量,对一种新型胃肠外头孢菌素抗生素头孢雷特的药代动力学进行了研究。在上述给药范围内,头孢雷特的药代动力学基本呈线性,血浆清除率在2.2至2.5升/小时之间变化。目前对该药物半衰期的最佳总体估计为2.9小时。肌肉注射头孢雷特的生物利用度为100%,静脉注射250毫克、500毫克和1000毫克,在30分钟输注结束时的峰值静脉血清水平分别为39微克/毫升、71微克/毫升和135微克/毫升;肌肉注射250毫克、500毫克和1000毫克后,各自的峰值血清水平分别为21微克/毫升、38微克/毫升和69微克/毫升。上述剂量的80%至85%以原形消除。